Mercanto Holdings Inc. Reports Fiscal 2025 Year-End Results

Executive Summary

• Mercanto Holdings reported a decline in revenue to $3.56 M and a net loss of $0.41 M for fiscal year ended July 31, 2025, driven by Quebec market restructuring.
• Cash balances increased to $395 K, but working capital fell sharply to $226 K, reflecting tighter liquidity.
• The company announced a grant of 1,300,000 stock options to senior executives at an exercise price of $0.12 per share.

Key Details

• Revenue: $3,561,289 (2024: $4,636,034) – −23% YoY.
• Net Revenue: $2,995,995 (2024: $3,893,410).
• Gross Margin: $621,689 (2024: $1,225,022) – ‑49% YoY.
• Net Income (Loss): $(412,313) (2024: $40,603) – net loss of $0.41 M.
• Cause of decline: Completion of Quebec’s province‑wide product rationalization, including delisting of certain SKUs and termination of the “nursery program.”
• Strategic outlook: New listings approved for six Quebec products (1 vape battery, 3 vape cartridges, 2 transitioned SKUs) expected to support revenue recovery in FY 2026.
• Liquidity – Cash: $394,974 as of July 31, 2025 (2024: $202,370).
• Liquidity – Working Capital: $225,910 (2024: $545,789).
• Stock Option Grants: 1,300,000 options granted to five executives (250,000 each to Eric Ronsse, Steve Saviuk, Michel Dahan, Franck Aton, Scott Jardin; 50,000 to Jerry Chen); exercise price $0.12 per share; vesting 50% on Nov 28, 2025 and remaining 50% one year later; ten‑year term.

Notable Quotes

• “While these measures had a negative short‑term impact on the Company's results, Mercanto believes they create long‑term structural benefits for established Quebec suppliers…” – Management commentary on market restructuring.